Multiple studies using in vivo colon cancer models showed that MEK inhibition potentiates the anti‐tumor immune response by preventing T cell apoptosis and decreasing levels of myeloid suppressor cells and regulatory T cells. The gene discussed is MAP2K7; the disease is neoplasm.